Aleksandra Senkova
Overview
Explore the profile of Aleksandra Senkova including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
14
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Awad M, Senkova A, Zenkova M, Markov O
Scand J Immunol
. 2025 Jan;
101(2):e70001.
PMID: 39865924
Myeloid-derived suppressor cells (MDSCs) are a heterogeneous group of immature myeloid cells playing a critical role in immune suppression. In vitro-generated MDSCs are a convenient tool to study the properties...
2.
Oshchepkova A, Chernikov I, Miroshnichenko S, Patutina O, Markov O, Savin I, et al.
Front Bioeng Biotechnol
. 2024 Nov;
12:1437817.
PMID: 39493304
Introduction: Small membrane particles called extracellular vesicles (EVs) transport biologically active cargo between cells, providing intercellular communication. The clinical application of EVs is limited due to the lack of scalable...
3.
Chiglintseva D, Clarke D, Senkova A, Heyman T, Miroshnichenko S, Shan F, et al.
Biomaterials
. 2024 May;
309:122604.
PMID: 38733658
Rationally-engineered functional biomaterials offer the opportunity to interface with complex biology in a predictive, precise, yet dynamic way to reprogram their behaviour and correct shortcomings. Success here may lead to...
4.
Vasileva N, Ageenko A, Byvakina A, Senkova A, Kochneva G, Mishinov S, et al.
Int J Mol Sci
. 2024 Apr;
25(8).
PMID: 38673835
Virotherapy is one of the perspective technologies in the treatment of malignant neoplasms. Previously, we have developed oncolytic vaccinia virus VV-GMCSF-Lact and its high cytotoxic activity and antitumor efficacy against...
5.
Gaponova S, Patutina O, Senkova A, Burakova E, Savin I, Markov A, et al.
Cancers (Basel)
. 2022 Sep;
14(18).
PMID: 36139555
Rational combinations of sequence-specific inhibitors of pro-oncogenic miRNAs can efficiently interfere with specific tumor survival pathways, offering great promise for targeted therapy of oncological diseases. Herein, we uncovered the potential...
6.
Alekseeva L, Senkova A, Savin I, Zenkova M, Mironova N
Int J Mol Sci
. 2021 Nov;
22(21).
PMID: 34769514
Tumor-associated cell-free DNAs (cfDNA) play an important role in the promotion of metastases. Previous studies proved the high antimetastatic potential of bovine pancreatic DNase I and identified short interspersed nuclear...
7.
Kolesnikova M, Senkova A, Tairova S, Ovchinnikov V, Pospelova T, Zenkova M
J Pers Med
. 2019 May;
9(2).
PMID: 31067780
Multidrug resistance (MDR) is a major challenge in leukemia treatment. The objective of this study was to identity predictors of MDR to allow for rapid and economical assessment of the...